Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
PETROCHINA
00857
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 238.63%10.27M | ---- | 48.67%-7.41M | ---- | -11,088.37%-14.43M | ---- | 98.55%-129K | ---- | 80.25%-8.89M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -72.22%-310K | ---- | -480.65%-180K | ---- | ---31K | ---- | ---- | ---- | ---- |
| Dividend (income)- adjustment | ---- | -0.64%-5.04M | ---- | -9.29%-5.01M | ---- | -3.03%-4.58M | ---- | -20.41%-4.45M | ---- | 4.99%-3.7M |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---315K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---315K |
| Revaluation surplus: | ---- | -233.00%-10.23M | ---- | -42.54%7.69M | ---- | 8,734.19%13.38M | ---- | -101.99%-155K | ---- | -81.47%7.77M |
| -Other fair value changes | ---- | -233.00%-10.23M | ---- | -42.54%7.69M | ---- | 8,734.19%13.38M | ---- | -101.99%-155K | ---- | -81.47%7.77M |
| Asset sale loss (gain): | ---- | --185K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | --185K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -4.38%-5.12M | ---- | 13.35%-4.91M | ---- | -19.69%-5.67M | ---- | 7.70%-4.73M | ---- | 21.05%-5.13M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 51.52%100K | ---- | 430.00%66K | ---- | -104.04%-20K | ---- | -17.22%495K | ---- | 164.60%598K |
| Accounts payable increase (decrease) | ---- | 470.00%57K | ---- | 42.86%10K | ---- | 124.14%7K | ---- | -163.64%-29K | ---- | -375.00%-11K |
| Financial assets at fair value (increase)decrease | ---- | 2,737.12%24.46M | ---- | -39.97%862K | ---- | 52.28%1.44M | ---- | 116.49%943K | ---- | ---5.72M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.05M | ---- | ---- |
| Cash from business operations | ---- | 590.78%19.49M | ---- | 6.39%-3.97M | ---- | -86.79%-4.24M | ---- | 77.86%-2.27M | ---- | 56.74%-10.26M |
| Dividend received - operating | ---- | 0.64%5.04M | ---- | 9.29%5.01M | ---- | 3.03%4.58M | ---- | --4.45M | ---- | ---- |
| Special items of business | -266.81%-12.68M | ---- | 177.23%7.6M | ---- | 219.09%2.74M | ---- | 138.66%859K | ---- | 58.26%-2.22M | --2.59M |
| Net cash from operations | -266.81%-12.68M | 2,261.02%24.53M | 177.23%7.6M | 203.80%1.04M | 219.09%2.74M | -84.30%342K | 138.66%859K | 128.40%2.18M | 58.26%-2.22M | 67.86%-7.67M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 110.57%259K | 72.22%310K | 151.02%123K | 480.65%180K | --49K | --31K | ---- | ---- | ---- | ---- |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.47%4.05M | -4.99%3.7M |
| Sale of subsidiaries | ---- | --195K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 110.57%259K | 180.56%505K | 151.02%123K | 480.65%180K | --49K | --31K | ---- | ---- | 29.47%4.05M | -4.99%3.7M |
| Net cash before financing | -260.80%-12.42M | 1,953.81%25.04M | 176.77%7.72M | 226.81%1.22M | 224.80%2.79M | -82.87%373K | -53.03%859K | 154.82%2.18M | 183.33%1.83M | 80.10%-3.97M |
| Cash flow from financing activities | ||||||||||
| Net Cash | -260.80%-12.42M | 1,953.81%25.04M | 176.77%7.72M | 226.81%1.22M | 224.80%2.79M | -82.87%373K | -53.03%859K | 154.82%2.18M | 183.33%1.83M | 80.10%-3.97M |
| Begining period cash | 451.75%30.58M | 28.20%5.54M | 28.20%5.54M | 9.44%4.32M | 9.44%4.32M | 122.91%3.95M | 122.91%3.95M | -69.16%1.77M | -69.16%1.77M | -77.66%5.75M |
| Cash at the end | 36.92%18.16M | 451.75%30.58M | 86.48%13.26M | 28.20%5.54M | 47.91%7.11M | 9.44%4.32M | 33.55%4.81M | 122.91%3.95M | 1.44%3.6M | -69.16%1.77M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.